1
Seventy-five had alcoholic cirrhosis and 435 had nonalcoholic cirrhosis of various etiologies.
2
Ten consecutive patients with known alcoholic cirrhosis and oesophageal variceal bleeding were included.
3
Liver transplantation for alcoholic cirrhosis remains controversial at some transplantation centers.
4
A 47-year-old woman presenting alcoholic cirrhosis was referred to our institution for refractory ascites.
5
The significant association was validated in the French patients with alcoholic cirrhosis and hepatocellular carcinoma.
6
Methods: Serum and circulating neutrophils were collected from patients with SAH, alcoholic cirrhosis and healthy controls.
7
Impact: These new biomarkers will be useful to manage patients with hepatocellular carcinoma developed on alcoholic cirrhosis.
8
Thirteen of 50 samples from patients with alcoholic cirrhosis had measurable D,L-2,3-butanediol.
9
For alcoholic cirrhosis the results were identical.
10
Fifty-three had the diagnosis of cirrhosis mentioned on the death certificate; of these, 36 had alcoholic cirrhosis.
11
Information about the outcome of patients who undergo transplantation for alcoholic cirrhosis would help to resolve these concerns.
12
The 54-year-old patient was 4 months after liver transplantation due to alcoholic cirrhosis.
13
Methods: We compared MnSOD genotypes in 94 control subjects and 264 patients with alcoholic cirrhosis.
14
Poor brain reserve in alcoholic cirrhosis could worsen insight regarding disease severity and increase the patients' vulnerability toward further deterioration.
15
In alcoholic cirrhosis, severity of liver disease is related to HVPG, collateral blood flow and degree of systemic circulatory abnormalities.
16
Compared with healthy individuals and patients with non-alcohol-related cirrhosis, alcoholic cirrhosis patients had increased systemic exposure and immune response to mycobiota.
